Personalised medicine means giving the right medicine in

the right dosage to the right group of patients at the right

time. Research involves developing methods to diagnose

and stratify patient populations to allow for targeted

treatment modifi ed to the gene expression and disease

profi le. This means that networking is one of the crucial

factors for creating the foundation for advances in the

fi eld of personalised medicine. Rasmus Beedholm-Ebsen

is Special Advisor within Life Science at Invest, and explains

how an advantage of a small country, like Denmark, is that

networking is easier, with fewer degrees of separation

between the scientist or scientifi c entrepreneur and the

decision-makers, like government ministers, policy-makers,

and industry leaders.